All the information you need about CG-BIOTECHNOLOGIE PHARMA to develop and secure your business in France

| Deposit | Confidentiality | closing date | document |
|---|---|---|---|
| 2022-11-25 | Public | 2021-12-31 | Complete |
| 2021-09-10 | Public | 2020-12-31 | Simplified |
| 2021-02-18 | Public | 2018-12-31 | Simplified |
| 2019-01-29 | Public | 2017-12-31 | Simplified |
| 2017-11-24 | Public | 2016-12-31 | Simplified |
| Name | CG-BIOTECHNOLOGIE PHARMA |
| Siren | 751348335 |
| Closing | 2016-12-31 |
| Registry code | 9401 |
| Registration number | 27122 |
| Management number | 2015B03068 |
| Activity code | 7211Z |
| Closing date n-1 | 2015-12-31 |
| Duration Fiscal year | 12 |
| Duration Fiscal year n-1 | 00 |
| Filing date | 2017-11-24 |
| Modification | 00 Annual accounts entered without anomaly |
| Balance sheet type | S : Simplified |
| Currency code | EUR |
| Confidentiality | Public |
| Address | 94000 CRETEIL |
| 1 - Assets and liabilities (balance sheet) | Gross amount N | Amortization year N | Net year N | Net year N-1 |
028 Tangible Assets | 8 222.00 | 2 099.00 | 6 123.00 | 8 222.00 |
040 Financial Assets | 4 500.00 | 4 500.00 | 4 500.00 | |
044 Total Fixed Assets | 12 722.00 | 2 099.00 | 10 623.00 | 12 722.00 |
060 Merchandise inventory | 7 260.00 | 7 260.00 | 7 260.00 | |
068 Receivables – Trade and related accounts | 906 880.00 | 906 880.00 | 906 880.00 | |
072 Receivables – Other | 28 376.00 | 28 376.00 | 28 376.00 | |
084 Cash | 75 274.00 | 75 274.00 | 75 274.00 | |
096 Total Current Assets + Prepaid Expenses | 1 017 790.00 | 1 017 790.00 | 1 017 790.00 | |
110 Total Assets | 1 030 512.00 | 2 099.00 | 1 028 413.00 | 1 030 512.00 |
120 Share or Individual Capital | 25 000.00 | |||
126 Legal Reserve | 2 500.00 | |||
134 Retained Earnings | 225 681.00 | |||
136 Profit for the Year | 76 703.00 | |||
142 Total Equity - Total I | 329 884.00 | |||
166 Suppliers and related accounts | 649 893.00 | |||
172 Other debts | 48 636.00 | |||
176 Total debts | 698 529.00 | |||
180 Liabilities Total | 1 028 413.00 | |||
| 2 - Income statement | Amount year N | Amount year N-1 | ||
209 Sales of goods – Export | 1 432 188.00 | 1 432 188.00 | ||
210 Sales of goods - France | 3 747 406.00 | 3 747 406.00 | ||
232 Total operating income excluding VAT | 3 747 406.00 | 3 747 406.00 | ||
234 Purchases of goods (including customs duties) | 3 354 825.00 | 3 354 825.00 | ||
236 Inventory change (goods) | -1 017.00 | -1 017.00 | ||
242 Other external expenses | 127 718.00 | 127 718.00 | ||
243 (including business tax) | 2 031.00 | 2 031.00 | ||
244 Taxes, duties and similar payments | 2 673.00 | 2 673.00 | ||
24B (including equipment leasing) | 3 566.00 | 3 566.00 | ||
250 Staff compensation | 111 610.00 | 111 610.00 | ||
252 Social security contributions | 41 612.00 | 41 612.00 | ||
254 Depreciation and amortization | 1 823.00 | 1 823.00 | ||
262 Other expenses | 2.00 | 2.00 | ||
264 Total operating expenses | 3 639 246.00 | 3 639 246.00 | ||
270 Operating profit | 108 160.00 | 108 160.00 | ||
290 Exceptional income | 14 248.00 | 14 248.00 | ||
294 Financial expenses | 3 712.00 | 3 712.00 | ||
300 Exceptional expenses | 13 003.00 | 13 003.00 | ||
306 Income tax's | 28 990.00 | 28 990.00 | ||
310 Profit or loss | 76 703.00 | 76 703.00 | ||
| 3 - Fixed assets - Depreciation - Capital gains, Capital losses | Amount for year N | |||
472 INCREASES Tangible Assets – Tangible Assets – Other Tangible Assets | 4 652.00 | 4 652.00 | ||
490 Total Fixed Assets (Gross Value) | 8 070.00 | 8 070.00 | ||
492 Total Fixed Assets (Increases) | 4 652.00 | 4 652.00 | ||
